Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075318470> ?p ?o ?g. }
- W2075318470 endingPage "2145" @default.
- W2075318470 startingPage "2136" @default.
- W2075318470 abstract "Following the recent discovery and development of 2-anilino-4-(thiazol-5-yl)pyrimidine cyclin dependent kinase (CDK) inhibitors, a program was initiated to evaluate related ring-constrained analogues, specifically, 2-methyl- and 2-amino-N-aryl-4,5-dihydrothiazolo[4,5-h]quinazolin-8-amines for inhibition of CDKs. Here we report the rational design, synthesis, structure−activity relationships (SARs), and cellular mode-of-action profile of these second generation CDK inhibitors. Many of the analogues from this chemical series inhibit CDKs with very low nanomolar Ki values. The most potent compound reported in this study inhibits CDK2 with an IC50 of 0.7 nM ([ATP] = 100 μM). Furthermore, an X-ray crystal structure of 2-methyl-N-(3-(nitro)phenyl)-4,5-dihydrothiazolo[4,5-h]quinazolin-8-amine (11g), a representative from the chemical series in complex with cyclin A−CDK2, is reported, confirming the design rationale and expected binding mode within the CDK2 ATP binding pocket." @default.
- W2075318470 created "2016-06-24" @default.
- W2075318470 creator A5002749363 @default.
- W2075318470 creator A5017202324 @default.
- W2075318470 creator A5018611126 @default.
- W2075318470 creator A5049970193 @default.
- W2075318470 creator A5055448105 @default.
- W2075318470 creator A5060862009 @default.
- W2075318470 creator A5066219838 @default.
- W2075318470 creator A5066645885 @default.
- W2075318470 creator A5070064687 @default.
- W2075318470 creator A5075500896 @default.
- W2075318470 creator A5076511286 @default.
- W2075318470 creator A5077566326 @default.
- W2075318470 creator A5081005693 @default.
- W2075318470 date "2010-02-10" @default.
- W2075318470 modified "2023-10-14" @default.
- W2075318470 title "Design, Synthesis, and Evaluation of 2-Methyl- and 2-Amino-<i>N</i>-aryl-4,5-dihydrothiazolo[4,5-<i>h</i>]quinazolin-8-amines as Ring-Constrained 2-Anilino-4-(thiazol-5-yl)pyrimidine Cyclin-Dependent Kinase Inhibitors" @default.
- W2075318470 cites W1536079196 @default.
- W2075318470 cites W1569698611 @default.
- W2075318470 cites W1593333678 @default.
- W2075318470 cites W1918601026 @default.
- W2075318470 cites W1966383348 @default.
- W2075318470 cites W1974600172 @default.
- W2075318470 cites W1990750564 @default.
- W2075318470 cites W1996350559 @default.
- W2075318470 cites W2010932256 @default.
- W2075318470 cites W2013908795 @default.
- W2075318470 cites W2014613601 @default.
- W2075318470 cites W2016329254 @default.
- W2075318470 cites W2016365699 @default.
- W2075318470 cites W2028210723 @default.
- W2075318470 cites W2029080338 @default.
- W2075318470 cites W2038696352 @default.
- W2075318470 cites W2039771541 @default.
- W2075318470 cites W2041638332 @default.
- W2075318470 cites W2060734153 @default.
- W2075318470 cites W2061158845 @default.
- W2075318470 cites W2069607377 @default.
- W2075318470 cites W2074631079 @default.
- W2075318470 cites W2076926270 @default.
- W2075318470 cites W2077165680 @default.
- W2075318470 cites W2078218463 @default.
- W2075318470 cites W2081342624 @default.
- W2075318470 cites W2081800369 @default.
- W2075318470 cites W2089020917 @default.
- W2075318470 cites W2097493124 @default.
- W2075318470 cites W2113604152 @default.
- W2075318470 cites W2126730534 @default.
- W2075318470 cites W2144434460 @default.
- W2075318470 cites W2146643673 @default.
- W2075318470 cites W2150217938 @default.
- W2075318470 cites W2154446841 @default.
- W2075318470 cites W2949097009 @default.
- W2075318470 cites W4376848281 @default.
- W2075318470 cites W2050271631 @default.
- W2075318470 doi "https://doi.org/10.1021/jm901660c" @default.
- W2075318470 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20146435" @default.
- W2075318470 hasPublicationYear "2010" @default.
- W2075318470 type Work @default.
- W2075318470 sameAs 2075318470 @default.
- W2075318470 citedByCount "30" @default.
- W2075318470 countsByYear W20753184702012 @default.
- W2075318470 countsByYear W20753184702013 @default.
- W2075318470 countsByYear W20753184702014 @default.
- W2075318470 countsByYear W20753184702015 @default.
- W2075318470 countsByYear W20753184702016 @default.
- W2075318470 countsByYear W20753184702017 @default.
- W2075318470 countsByYear W20753184702018 @default.
- W2075318470 countsByYear W20753184702019 @default.
- W2075318470 countsByYear W20753184702020 @default.
- W2075318470 countsByYear W20753184702021 @default.
- W2075318470 countsByYear W20753184702022 @default.
- W2075318470 countsByYear W20753184702023 @default.
- W2075318470 crossrefType "journal-article" @default.
- W2075318470 hasAuthorship W2075318470A5002749363 @default.
- W2075318470 hasAuthorship W2075318470A5017202324 @default.
- W2075318470 hasAuthorship W2075318470A5018611126 @default.
- W2075318470 hasAuthorship W2075318470A5049970193 @default.
- W2075318470 hasAuthorship W2075318470A5055448105 @default.
- W2075318470 hasAuthorship W2075318470A5060862009 @default.
- W2075318470 hasAuthorship W2075318470A5066219838 @default.
- W2075318470 hasAuthorship W2075318470A5066645885 @default.
- W2075318470 hasAuthorship W2075318470A5070064687 @default.
- W2075318470 hasAuthorship W2075318470A5075500896 @default.
- W2075318470 hasAuthorship W2075318470A5076511286 @default.
- W2075318470 hasAuthorship W2075318470A5077566326 @default.
- W2075318470 hasAuthorship W2075318470A5081005693 @default.
- W2075318470 hasConcept C124320809 @default.
- W2075318470 hasConcept C131779359 @default.
- W2075318470 hasConcept C1491633281 @default.
- W2075318470 hasConcept C171250308 @default.
- W2075318470 hasConcept C178790620 @default.
- W2075318470 hasConcept C181199279 @default.
- W2075318470 hasConcept C184235292 @default.
- W2075318470 hasConcept C185592680 @default.
- W2075318470 hasConcept C192562407 @default.
- W2075318470 hasConcept C193042331 @default.